MedImmune
Maryland · Founded 1987
About MedImmune
MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.
Company Facts
- Founded: 1987
- Legal name: AstraZeneca PLC.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 5,001 – 10,000
- Estimated revenue: $100K – $500K
- Website: medimmune.com
- Phone: 301-398-0000
Social Profiles
Canonical: https://fsome.com/organization/medimmune-8441412 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.